Notably, MFN2 loss was associated with myocardial hypertrophy in cardiac tissue, while gene delivery of an adenoviral vector‐encoding rat MFN2 proved to successfully protect against myocardial hypertrophy (Yu et al. 2011). Here, MFN2 is linked to cardiac hypertrophy.